Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: results with four tyrosine kinase inhibitor modalities

Early responses to tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML)-chronic phase (CP) are associated with improved outcome. We analyzed the impact of such a response on outcomes among patients treated with 4 TKI modalities as frontline therapy in CML-CP. A total of 483 patients w...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Jain, Preetesh, Kantarjian, Hagop, Nazha, Aziz, O’Brien, Susan, Jabbour, Elias, Romo, Carlos Guillermo, Pierce, Sherry, Cardenas-Turanzas, Marylou, Verstovsek, Srdan, Borthakur, Gautam, Ravandi, Farhad, Quintás-Cardama, Alfonso, Cortes, Jorge
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2013
Gaiak:
Clinical Trials and Observations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3743466/
https://ncbi.nlm.nih.gov/pubmed/23620574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-03-490128
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak